X0202
SCHEDULE 13G/A
0001193125-18-045775
0001319998
XXXXXXXX
LIVE
3
Common Shares, no par value
06/30/2026
0001211583
Fennec Pharmaceuticals Inc.
31447P100
PO Box 13628
68 TW Alexander Drive
Research Triangle Park
NC
27709
Rule 13d-1(d)
Southpoint Master Fund, LP
E9
0
0
0
0
0
N
0
PN
Southpoint Capital Advisors LP
DE
0
0
0
0
0
N
0
PN
Southpoint Capital Advisors LLC
DE
0
0
0
0
0
N
0
OO
Southpoint GP, LP
DE
0
0
0
0
0
N
0
PN
Southpoint GP, LLC
DE
0
0
0
0
0
N
0
OO
John S. Clark II
X1
0
0
0
0
0
N
0
IN
Fennec Pharmaceuticals Inc.
PO Box 13628, 68 TW Alexander Drive, Research Triangle Park, NC 27709
The names of the persons filing this report (the "Reporting Persons") with respect to the Common Shares, no par value (the "Common Shares") of Fennec Pharmaceuticals Inc. (the "Issuer") are:
(i) Southpoint Master Fund, LP
(ii) Southpoint Capital Advisors LP
(iii) Southpoint Capital Advisors LLC
(iv) Southpoint GP, LP
(v) Southpoint GP, LLC
(vi) John S. Clark II
The address of the principal business office of each of the Reporting Persons is:
1114 Avenue of the Americas, 22nd Floor, New York, NY 10036
Southpoint Master Fund, LP: Cayman Islands
Southpoint Capital Advisors LP: Delaware
Southpoint Capital Advisors LLC: Delaware
Southpoint GP, LP: Delaware
Southpoint GP, LLC: Delaware
John S. Clark II: United States of America
Y
The information required by this item with respect to each Reporting Person is set forth in Rows 5 through 9 of the cover pages to this Schedule 13G.
The information required by this item with respect to each Reporting Person is set forth in Row 11 of the cover pages to this Schedule 13G.
The information required by this item with respect to each Reporting Person is set forth in Row 5 of the cover pages to this Schedule 13G.
The information required by this item with respect to each Reporting Person is set forth in Row 6 of the cover pages to this Schedule 13G.
The information required by this item with respect to each Reporting Person is set forth in Row 7 of the cover pages to this Schedule 13G.
The information required by this item with respect to each Reporting Person is set forth in Row 8 of the cover pages to this Schedule 13G.
N
Y
Y
Y
Y
Y
Y
Southpoint Master Fund, LP
/s/ John S. Clark II
By Southpoint GP, LP, its General Partner, by Southpoint GP LLC, its General Partner, by John S. Clark II, Managing Member
08/14/2026
Southpoint Capital Advisors LP
/s/ John S. Clark II
By Southpoint Capital Advisors LLC, its General Partner, by John S. Clark II, Managing Member
08/14/2026
Southpoint Capital Advisors LLC
/s/ John S. Clark II
John S. Clark II, Managing Member
08/14/2026
Southpoint GP, LP
/s/ John S. Clark II
By Southpoint GP, LLC, its General Partner, by John S. Clark II, Managing Member
08/14/2026
Southpoint GP, LLC
/s/ John S. Clark II
John S. Clark II, Managing Member
08/14/2026
John S. Clark II
/s/ John S. Clark II
John S. Clark II, individually
08/14/2026